within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05B_IVSolutions.B05BB01_Electrolytes;

model Electrolytes
  extends Pharmacolibrary.Drugs.ATC.B.B05BB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B05BB01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Electrolytes with ATC code B05BB01 are intravenous solutions containing various combinations of essential ions such as sodium, potassium, calcium, magnesium, chloride, and bicarbonate. They are commonly used for fluid and electrolyte replenishment in cases of dehydration, electrolyte imbalance, and during surgery or intensive care. These solutions are widely approved and are a mainstay in clinical practice to restore or maintain normal electrolyte balance.</p><h4>Pharmacokinetics</h4><p>There are no specific pharmacokinetic models or parameter publications describing the multi-electrolyte solutions as a whole because each ion component (e.g., sodium, potassium) follows its own physiological kinetics, and product formulations vary widely. Pharmacokinetic parameters are therefore not directly applicable to 'electrolytes' as a combined drug entity.</p><h4>References</h4><ol><li><p>Rizoli, S (2011). PlasmaLyte. <i>The Journal of trauma</i> 70(5 Suppl) S17–S18. DOI:<a href=\"https://doi.org/10.1097/TA.0b013e31821a4d89\">10.1097/TA.0b013e31821a4d89</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21841561/\">https://pubmed.ncbi.nlm.nih.gov/21841561</a></p></li><li><p>Carrasco, MJ, et al., &amp; Buschmann, MD (2021). Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. <i>Communications biology</i> 4(1) 956–None. DOI:<a href=\"https://doi.org/10.1038/s42003-021-02441-2\">10.1038/s42003-021-02441-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34381159/\">https://pubmed.ncbi.nlm.nih.gov/34381159</a></p></li><li><p>Mroszczak, EJ, et al., &amp; Massey, I (1990). Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. <i>Pharmacotherapy</i> 10(6 ( Pt 2)) 33S–39S. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2082311/\">https://pubmed.ncbi.nlm.nih.gov/2082311</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Electrolytes;
